1.3700
-0.0800
(-5.52%)
At close: January 10 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 146k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 438k |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.08 | -0.06 | -0.06 | -0.06 |
| EPS Actual | -0.07 | -0.2 | -0.05 | -0.05 |
| Difference | 0.01 | -0.14 | 0.01 | 0.01 |
| Surprise % | 8.70% | -233.33% | 16.67% | 16.67% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MDNA.TO | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/6/2024 |
| Initiated | Oppenheimer: Outperform | 12/18/2020 |
| Initiated | Oppenheimer: Outperform | 12/17/2020 |
| Initiated | HC Wainwright & Co.: Buy | 9/10/2020 |
Related Tickers
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
TH.TO Theratechnologies Inc.
2.6900
-7.88%
SVA.TO Sernova Corp.
0.2250
0.00%
ARCH.V Arch Biopartners Inc.
1.9500
+1.04%
MSCLF Satellos Bioscience Inc.
0.6130
+2.17%
DRUG.CN Bright Minds Biosciences Inc.
56.00
-3.25%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%